Champions Oncology 1st Annual Oncology Drug Discovery Symposium
Due to overwhelming demand, this event is now at full capacity
Join the wait list.
Registrants will typically notify us prior to the event if they are no longer able to attend. We will notify you as soon as possible when a seat becomes available.
Please complete the form to the right to join the wait list and kindly provide your mobile number to allow us to quickly contact you via text message to confirm your seat.
Register for Champions Oncology 1st Annual Oncology Drug Discovery Symposium in Cambridge, UK
Wednesday 12th June, 9:00-17:00, Babraham Research Campus
The Cambridge Building, King’s Hedges conference room
Support your oncology or immuno-oncology drug development programs, from preclinical testing, to translational studies, to research in the clinic, by attending the Champions Oncology drug discovery symposium. Learn from experts about current solutions and approaches for today’s needs and innovative techniques for tomorrow’s challenges.
Who Should Attend:
R&D, discovery, preclinical and translational teams from pharma, biotech, and academia
- Organoid 2.0: towards in vitro oncology trials
- How to optimise the use of PDX models to run effective in vivo pre-clinical trials
- Next-generation humanised mouse models for immuno-oncology
- Novel approaches to targeting immunosuppression in cancer
Dr. Rebecca Marlow, Staff Scientist: Patient-Derived Models Team, Institute Cancer Research
Dr. Nicholas Floch, Associate Prinical Scientist, AstraZeneca
Dr. Gavin Bennett, Director, Project Lead, Bicycle Therapeutics
Dr. Phillip Dube, Senior Manager, Appication Sciences, Taconic
Dr. Aleksandra Flipovic, Therapeutic Lead, Oncology, Puretech Health
Dr. Mustapha Faroudi, Senior Scientist, Preclinical Translational Phamacology, F-star
Dr. Jayesh Majithiya, Senior Scientist, Crescendo Biologics
Dr. Amy Wesa, Director Immuno-Oncology Research, Champions Oncology